Users-Clinical-Cases 1607 Rev2 Web
Users-Clinical-Cases 1607 Rev2 Web
Users-Clinical-Cases 1607 Rev2 Web
Contents 10 Dr. Tae-Hyeong Kim 32 Dr. Jong-Chan Park 44 Dr. Kyung-Man Min 56 Dr. Won-Kyu Kim 68 Evaluation of Different Combinations
Kim & Lee Dental Clinic Ye Dental Clinic Seoul Mai Dental Clinic Prime Dental Clinic of Biphasic Calcium Phosphate and
Growth Factors for Bone Formation
12 Dr. Gwan-Taek Jo 34 Dr. Lae-Jung Park 46 Dr. Hyun-Sik Park 58 Dr. Ha-Young Kim
in Calvarial Defects in a Rabbit Model
Yes Dental Clinic Trip Dental Clinic Haim Dental Clinic Korea University Guro Hospital
16 Dr. Won-Bae Park 38 Dr. Seung-Min Han 50 Dr. Hyun-Suk Lee 62 Prof. Sang-Wan Shin 84 Dr. Dong-Wook Chang
Parkwonbae Dental Clinic Seoul Ichon Dental Clinic GwanghwamunYe Dental Clinic Korea University Guro Hospital Win Dental Clinic
18 Dr. Jong-Chan Park 40 Dr. Yung-Jin Cho 52 Prof. Ui-Won Jung 64 Prof. Jeong-Yul Lee 86 Dr. Seung-Min Han
PyeongchonYe Dental Hospital Seoul Ppusigipeon Dental Clinic Department of Periodontology, Korea University Guro Hospital Seoul Ichon Dental Clinic
Yonsei University College of Dentistry
20 Dr. Se-Ung Oh
Hwain Dental Hospital
26 Dr. Joon-Young Jo
Jojoonyoung Dental Clinic
16 18 20
Long-term Dr. Won-Bae Park
Parkwonbae Dental Clinic
Dr. Jong-Chan Park
PyeongchonYe Dental Hospital
Dr. Se-Ung Oh
Hwain Dental Hospital
22 24 26
Dr. Seung-Min Han Dr. Il-Woo Jang Dr. Joon-Young Jo
Seoul Ichon Dental Clinic Seongwon well Dental Clinic Jojoonyoung Dental Clinic
28
Prof. Young-Gyun Kim
Seoul National University
Bundang Hospital
10 Long-term Follow up Clinical Cases Long-term Follow up Clinical Cases 11
Surgical Approach
After waiting for 3 weeks after extracting #36, 37 early implant placement
was performed after soft tissue on the extraction socket healed to some
degree, and submerged type was placed. 7 week post-operatively,
2nd surgery was performed.
Prosthetic Approach
Combi abutment was tightened with 25 Ncm and was connected and then 6/24/2004 Final prosthesis 6/24/2004 Final prosthesis
provisional restoration was installed. 1 week later, combi abutment was
retightened with 25 Ncm, and 2nd impression was taken to finish and install
the final prosthesis.
Conclusion
On the molar area of male patient with no severe mastication force,
regular diameter Implantium implant functions excellently.
C.C.
Patient had problems with eating due to missing molar teeth.
Surgical Approach
Due to clinical limit of residual bone volume, a procedure of alveolar bone
augmentation in vertical dimension was performed for attaining initial stability
of implant It enabled putting minimum effort of drilling and self-tapping
for implantation.
6/20/2005 Final prosthesis 3/14/2007 2 years follow up
Prosthetic Approach
Showed equal mastication force with remaining teeth
Removed premature contact in case lateral movement had been made.
Conclusion
Now, after 10 years later of implantation, bone resorption has not been observed
through X-ray. Also, there was no screw-loosening of implant at both maxilla
and mandible. (SCRP Type)
Surgical Approach
1) Chase allograft as the bone grafting material to be used for this
particular case
2) Simultaneous implantation based on the initial stability to reduce
treatment time
3) Minimal drilling and self-threading for initial fixation Place the implant
deeply into the bone due to the reduced residual bone from the
previous implant failure
Conclusion
The implant has been well maintained without bone loss for 10 years.
It has been identified during the follow up that while a natural tooth
was extracted and replaced with an implant.
The bone condition of the original implant has been well maintained
without any problems.
Surgical Approach
1) Both second molars (hopeless teeth) in the left and right maxilla were extracted,
and four IMPLANTIUM (3.8 x 12 mm) of Dentium were placed after 1 month.
Bone graft was performed in the extraction and missing teeth area using a xenogenic
bone, and membrane was not used
2) After 4 months, the second stage surgery was performed, and the final prosthesis
was installed after 6 months
5/19/2003 Final prosthesis 5/23/2005 2 years follow up
3) The patient visited the clinic after 2 years and 10 years and was evaluated
with clinical testing and panoramic imaging. The result was shown satisfactory
since the gingiva near abutment was tightly sealed, and crestal bone was
stabilized with no change
Branemark affiliated implants have been the industry standard for over 30 years due to a large
amount of long-term clinical data that can be found. Long-term data offers important information
on the life of implant, improvement and development of the implant design, and the choice of the
implant. For the case of well-known implants by famous global brands, it is clear that there have
been a lot of data accumulated with published researches. This is how brands become famous
and recognized. In order to obtain long-term data, it requires great effort and time.
What can we say about lesser known domestic implants? There is short-term data available,
however, many new products had been released even before most short-term data were
presented. For the selection of an implant, it is necessary to observe the survival rate and the
changes in the crestal bone for at least 5 years. Survival rates of the implants currently in the
market vary from 90% to 98%. On the basis of Branemark data, Adell (1981) showed an absorption 1/17/2013 10 years follow up 1/10/2014 11 years follow up
of 1 - 1.5 mm for the first year and 0.1 - 0.2 mm each year afterwards, which is assumed to be in the
normal range. What about Dentium implants? Cases that lasted over 2 years from the 584 implants
used in 166 patients were collected. Follow-up of long-term clinical data of 10 years on those cases
were also performed. The average recall period was 67.04 months and 4 implants among those
failed. A very high survival rate of 99.32% was shown. Also, the frequency of bone resorption was
5.82% and the average of bone resorption rate was 0.21 mm/implant, which is very low.
Crestal bone resorption rate was much lower than revealed in the Branemark data.
The crestal bone response has been shown to be very stable.
Conclusion
In conclusion, Dentium implant showed an outstanding clinical efficiency
when it is compared with other overseas and domestic imlants.
If more resrearches are conducted, its credibility will be even strengthened.
18 Long-term Follow up Clinical Cases Long-term Follow up Clinical Cases 19
Surgical Approach
Since there were few residual bones in maxilla (residual ridge height
from alveolar crest was only 3 - 4mm), maxillary sinus lift was performed
after a tooth extraction. After approximately 7 months, an implant was
placed in a more accurate location using a pre-fabricated surgical guide.
As seen from the picture, the early stage of IMPLANTIUM had a mount,
which greatly helped in determination of a placement direction.
A protocol about the placement period at that time was to exert loading
6 months after the placement; however, in this case, loading by temporary 11/2/2005 Final prosthesis 8/22/2007 2 years follow up
crown was done at 4.7 months and the final prosthesis was installed
approximately after 2 months.
Prosthetic Approach
In order to reduce the number of placement, it was planned to use a bridge
type for both maxilla and mandible. In addition, abutments with various
gingival heights were used to avoid an exposure of metal collar.
Following the protocol practiced at that time, the distal side of the 2nd molar,
which was the most prone to the fracture, was treated with metal coverage
to give a protection against fracture.
10 years have passed and there is no fracture on porcelain tooth.
7/8/2010 5 years follow up 1/8/2013 10 years follow up
Conclusion
10 years report of Implantium treated with S.L.A. (Sandblasting with Large
grits and Acid etching) surface of Dentium was presented.
Radiographs have shown that bone response is excellent and it is maintained
well with no screw loosening up to the present moment.
Margin of prosthesis was not as accurate as today since it was difficult for the
initial impression coping to obtain a precise location within the impression
material; however, it has been maintained well without cement leakage.
20 Long-term Follow up Clinical Cases Long-term Follow up Clinical Cases 21
Surgical Approach
Judging from the degree of abrasion of the residual teeth although there was
no bad habit, mastication force over medium level was expected, and wide
implant was thus planned. The bone width of the patient was appropriate.
1) Implant length is decided based on the measurement of the possible
bone height because implant gets more deeply positioned with its depth
being over 0.5 mm away from the bone crest as the diameter becomes wider.
2) Implant with appropriate depth is chosen, knowing the location and runway
angle of mental foramen on the 2nd premolar area under CT image. 11/1/2006 Final prosthesis 10/13/2009 6 years follow up
Prosthetic Approach
In an old bilateral loss condition, to compensate the change of the expected
height and mandibular position, ready-made combi abutment was connected,
and occlusion on the posterior teeth area was slightly raised in provisional
resin restoration condition, and the occlusion point that coincides with the
tooth axis was provided. After observing and reinforcing the sinking
phenomenon, final restoration was done with gold crown 6 weeks later.
Conclusion
Personally, I have experienced a huge difference of occurrence rate of 3/15/2012 8 years follow up 2/11/2014 10 years follow up
peri-implantitis which is characteristic is comparative observation between
so called luxury foreign implants and many domestically manufactured
implants having fragmentary but regular surgical procedures and criteria.
Compared to this, long term result of tissue reaction of Dentium implant
seems to be very positive.
22 Long-term Follow up Clinical Cases Long-term Follow up Clinical Cases 23
C.C.
The patient requested an implant placement.
Conclusion
It is considered to be a successful case in the long term since cortical
bone near marginal bone is retained well and even gained 11/4/2005 2 years follow up 5/8/2013 10 years follow up
by functional remodeling. As a result of comparison of radiographs
taken immediately after installation of the prosthesis with radiographs
taken 10 years after the marginal bone gaining was observed.
Cortical bone around implants has been maintained in good condition.
It would be fair to expect positive results in the long run.
24 Long-term Follow up Clinical Cases Long-term Follow up Clinical Cases 25
Prosthetic Approach
After connecting dual AB, cement type porcelain crown was installed.
Since the patient was meticulous on oral hygiene, no special treatment
except for a regular check up and partial occlusal adjustment has been done
since 2003, and there is no finding of bone resorption.
augmentation by functional
remodeling
Dr. Joon-Young Jo / Jojoonyoung Dental Clinic
C.C.
Patient requested for implant placement in mandibular left and right molar. 6/30/2003 Preoperative 7/4/2003 Postoperative (#35, 36)
Surgery Aspect
After 2weeks of #36 and #37 implantation, #36 cover screw had been exposed
a little and so it was replaced with healing abutment.
4312 was implanted in #36 and 4310 was implanted in #37. 7/31/2003 Postopertive (#44, 45, 46) 7/31/2003 Final prosthesis
3412 was implanted in #44 and 3812 was implanted in #46.
Bone graft was not performed.
Prosthetic Aspect
Thin diameter implants were placed in #44, #45, and #46 due to narrow bone width.
Therefore, splint with prosthesis was considered.
Until now, for 10 years, there had been no problem with implant.
Conclusion
After 2 months prosthesis had been installed, patient has shown favorable
outcome until now. 10/4/2012 9 years follow up 4/1/2014 11 years follow up
Bone resorption was hardly observed. Gingival recession was happened
a little, but still it remains healthy.
28 Long-term Follow up Clinical Cases Long-term Follow up Clinical Cases 29
Surgical Approach
Installed small diameter implant (lmplantium 3.4D/ML) for the surgical
operation of ridge expansion on tooth #22.
To minimize damages on the cortical bone of the labial, I applied bone
graft material into the interior of the labial while flap reflectionwas minimized.
Prosthetic Approach
I maintained convexity for the gingival of the labial, while I was conducting the 7/15/2003 Implantation 7/15/2003 Postoperative
second surgery with the surgical method of palatal roll-in after six months
of the implantation. Temporary prosthesis using Combi Abutment
(2mm GH / 41.80) were placed for three months and then were ultimately
replaced with the final prosthesis. (prosthesis treatment: Prof. Jung-won Hwang)
Conclusion
Having passed 10 years and 6 months since the implantation, gingival
retraction and resorption of marginal bone have been hardly noticed.
The esthetic prosthesis have been maintained well.
1/13/2004 Second stage surgery 3/17/2005 1 year follow up 3/15/2015 11 years follow up
32 34 36
Dr. Jong-Chan Park Dr. Lae-Jung Park Dr. Dong-Wook Chang
Ye Dental Clinic Trip Dental Clinic Win Dental Clinic
Surgical Approach
AS can be seen in the bone graft procedure scene using the OSTEON II Sinus,
it is evident that the blood permeated well in between the bone graft material.
Judging from this behavior, it is provided that it allowed a favorable environment
for new bone growth.
Prosthetic Approach 4/19/2012 Sinus detaches using DASK 4/19/2012 OSTEON II Sinus
In case of implementing the alveolar process in the maxillary premolar
region, the augulation of the implant placement may be off.
Therefore, CCM abutment was utilized to create the full zirconia crown.
Conclusion
It was very dffective to utilize the OSTEON II Sinus, for bone graft procedure
in the maxilla with insufficient residual bone depth. Moreover, it was highly
effective when OSTEON II Collagen was used to increase the bone volume.
Prosthetic Aspect
After fixture level impression had been made with a transfer coping,
customized abutment was restored with zirconia crown. 1/19/2013 OSTEON II 1/19/2013 Collagen Membrane
Conclusion
GBR was performed using OSTEON ll and Collagen Membrane for buccal bone
deficiency healing. As a result, excellent new bone formation with sufficient quantity
and appropriate bone contour healing were observed.
C.C.
Tooth mobility and pain on #23 due to endo-perio combined lesion.
Surgical Approach
A severe bone loss on #23 was observed in X-ray and buccal gingival recession Implantation Collagen Membrane
was severe to damage esthetics. To recover these, implant restoration accompanying
alveolar ridge preservation and GBR was planned to gain esthetics back.
Conclusion
For recovery of esthetics on upper canine which shows pain, Mobility, pus discharge
and a severe gingival recession due to endo-perio combined lesion, alveolar ridge
preservation during extraction by using soft tissue was performed and implant
installation was done with GBR after soft tissue healing.
Through these two processes, restoration with esthetics was able to be performed.
Suture Healing 4 months
C.C.
Id like my teeth treated because they are wobbly.
Preoperative Implantation
Surgery Key Point
Critical size defect on lower 2nd molar area was recovered by immediate
implantation by using Collagen Membrane and OSTENON II combined with
autogenous bone.
Surgery Aspect
1) To position the implant at a right location and to recover the critical
size defect caused simultaneously, GBR technique was used.
2) The fact that choosing the right bio material(membrane, bone graft)
brings about a good result is confirmed. OSTEON II Collagen Membrane
3) For a good primary closure, proper healing period is provided.
Prosthetic Aspect
Appropriate occlusion of single implant on the most posterior
2nd molar is accomplished.
Conclusion
OSTEON II used to recover critical size defect was found to have been well
harmonized with newly formed bone when re-entry was tried, and it was
confirmed that the volume maintenance was also good. Also, excellent Suture Second stage surgery
manipulation, biocompatibility, and barrier function that sufficiently
protects the new tissue of Collagen Membrane were confirmed.
C.C.
All teeth are wobbly I have difficulties in eating.
Conclusion
Although it was a contained defect, bone graft surgery using OSTEON II
and Genoss Collagen Membrane were confirmed to be successful on a large
defect with over 10 mm size.
2/19/2014 Postoperative 3/25/2014 Healing 1 month
Narrow Implant
50 52
Dr. Hyun-Suk Lee Prof. Ui-Won Jung
Gwanghwamun Department of Periodontology
Ye Dental Clinic Yonsei University
College of Dentistry
44 Narrow implant Clinical Cases Narrow implant Clinical Cases 45
C.C.
4/30/2014 Preoperative 4/30/2014 Preoperative
Teeth are wobbly and painful.
Prosthetic Key Point 4/30/2014 Implantation (NR Line 3011S) 4/30/2014 Bone graft (OSTEON II Collagen)
Prior to nal impression, the Temporary cylinder was used to fabricate
provisional restoration for soft tissue modeling.
Furthermore, the customized abutment was milled to provide adequate
biologic width around the implant.
Conclusion
When we install implant at the very narrow alveolar ridge,the 3.0mm diameter
NR Line implant is the proper selection. Especially when the orientation of the
osteotomy and the restoration is dierent, a two-piece implant/abutment option
is better than the one-piece SlimLine implant. Moreover, when the space is limited 4/30/2014 Suture 9/24/2014 Final prosthesis
and the soft tissue level is irregular in shape, it is eective to use a customized
abutment to achieve adequate biologic width around the implant.
C.C.
6/13/2013 Preoperative 11/22/2013 Preoperative
Teeth are wobbly and painful.
Conclusion
Alveolar bone grafting was performed because alveolar bone resorption was
severe, but interdental space problem was solved by prosthetis since alveolar
bone and gingival formation was insufficient on the distal side.
on narrow space
Dr. Seung-Gun Lee / Gongreung Seoul Dental Clinic
C.C.
Fiber post&core and PFM crown restored on #12 fell off.
7/29/2014 Preoperative 7/29/2014 Extraction
Surgery Key Point
Fixed implant prosthesis was restored due to the loss of #13. To avoid the
formation of the incision line from surgery, immediate implantation with
flapless surgery was performed. Because the absorption of buccal alveolar
bone was expected, OSTEON II Collagen with excellent manipulation was
filled -together on the extraction socket to compensate it.
Conclusion
Because immediate implantation using NR Line implant was done, the tissue
that could be easily damaged was well saved and the procedures were
thus able to be successfully finished through implant restoration.
C.C.
Broken front tooth.
Conclusion
Through the aggresive thread, it was possible to achieve a high initial stability
and a smooth implant xation.
C.C.
Patient wants to have implant placed where her premolar fractured.
Conclusion
From the beginning to the nal prosthesis connection took 3 months.
The treatment resulted in a highly satisfactory outcome, both esthetically
and functionally.
Overdenture
Guro Hospital
62 64
Prof. Sang-Wan Shin Prof. Jeong-Yul Lee
Korea University Korea University
Guro Hospital Guro Hospital
56 Overdenture Clinical Cases Overdenture Clinical Cases 57
Surgery aspect
1) For an accurate implant positioning, surgical stent is made
2) Parallelism of the implants is maintained
3) Sufficient irrigation to avoid overheating 9/26/2013 Implantation 12/26/2013 Magnetic attachment
4) proper tapping considering bone density
5) Installation with appropriate torque to avoid compressive bone necrosis
Prosthetic aspect
1) Should have sufficient retentive force for denture retention
2) Should be stable against lateral force
3) Harmful force should not be applied to the implant fixture.
4) Should be able to choose an attachment with appropriate height
considering the thickness of the mucosa.
12/26/2013 Final prosthesis 12/26/2013 Final prosthesis
Considering the above aspects, dome type magnetic
attachment of Dentium was chosen finally.
Conclusion
As a result of applying magnetic attachment after a sufficient time period
(3 months) on a complete denture which had made in advance, it is proven
that it is a method with a high level of satisfaction since patient discomforts
such as denture loosening or pain disappeared.
overdenture
Dr. Ha-Young Kim / Korea University Guro Hospital
C.C.
I would like a new denture made.
Surgery aspect
Since Simpleline II is non-submerged type, it lessened the burden of 2nd surgery
on aged patient, and the treatment procedures were relatively simple.
Prosthetic aspect
Since the head part of the ball abutment is small, it could be utilized usefully,
and O-ring on the inner surface of metal housing had sufficient retention 11/30/2011 Implantation 11/30/2011 Postoperative
force that aged patients could place and remove with no problem, and smooth
placement and removal was felt as well from an operators point of view.
Since O-ring could be replaced when it becomes worn out, and this also
lessens the burden of maintenance and repair cost.
Conclusion
Implant overdenture using Simpline II and ball attachment is simple in its
procedures, and prosthetic treatment, repair and maintenance are also
easy, so it is expected that it will be actively utilized in the future.
2/8/2012 Ball attachment connection 10/18/2012 10 months follow up
60 Overdenture Clinical Cases Overdenture Clinical Cases 61
C.C.
Bottom teeth are wobbly.
11/9/2011 Preoperative 11/21/2011 Postoperative
Surgery Key Point
Since installation location could be freely chosen, the case which accompanies
a complex and challenging procedures such as bone grafting could be minimized,
and the possibility of the occurrence of complication such as inferior alveolar
nerve damage could be minimized.
Conclusion
In mandible, stability of implant used for (implant-tissue supported)
overdenture could be sufficiently secure without splinting the implants unlike
bar type where implants must be splinted. If positioner is used, a sufficiently
stable overdenture will be provided with minimum implant numbers and the
cost for fabrication and maintenance will be low. Also, the convenience of the 5/2/2012 Final prosthesis 1/4/2013 1 year Follow up
maintenance is excellent.
C.C.
My denture falls off. 9/22/2011 Preoperative 9/22/2011 Implantation (SimpleLine II)
Prosthetic aspect
1 week after implant installment, the inner surface of the denture was adjusted 10/31/2011 Postoperative 11/8/2011 Healing 2 weeks (#43, #33)
so that the patient could use the denture.
2 months later, ball attachment was connected with 35 Ncm force, and to
connect the female attachment to the denture, pick-up impression was
taken with indirect method by using ball impression coping for pick-up
impression after forming holes on the existing denture. The female matrix
of the ball attachment was connected to the attachment, and the undercut
on the lower part was blocked-out by using fit-checker, and self curing resin
was added, and then relining was done by using priorly made occlusal index
After trying in the overdenture to the patient, its inner surface was adjusted
by using fit-checker. After installing the overdenture, patient satisfaction
1/9/2012 Mini ball attachment 1/9/2012 Final prosthesis
level was high, and it was found that the denture was well maintained
in several regular follow-ups.
Conclusion
Mandibular overdnture by using 2 implants has many advantages such as clinical
success rate, patient satisfaction, cost, lessening of the burden of the surgery on
the patient etc.
overdenture
Prof. Jeong-Yul Lee / Korea University Guro Hospital
C.C.
Id like to participate in clinical experiment of implant overdenture.
3/22/2012 Preoperative 3/22/2012 Preoperative
Surgery aspect
Installation was done with the length being measured according to the highest
bony tuberosity portion due to irregularities of tuberosity on the alveolar crest.
5/8/2012 Implantation (#43, #33) 5/2/2012 Postoperative
Prosthetic aspect
Because the condition of the denture was good, and the fit was also good, the
female was attached to the denture in direct method without relining procedure.
Conclusion
Overdenture was functioning well without any significant note, and bone loss
around implant or periodontal condition showed a successful result. Patient
satisfaction level was high as well.
Research Paper
and Growth Factors for Bone Formation
in Calvarial Defects in a Rabbit Model
Evaluation of Different
Evaluation of Different Combinations of Biphasic Calcium Phosphate
and Growth Factors for Bone Formation in Calvarial Defects in a Rabbit Model
Combinations of Biphasic Calcium Phosphate The aim of the present preclinical study was to investigate the capability of a new formulation
and Growth Factors for Bone Formation of biphasic calcium phosphate (BCP) in achieving new bone formation either by itself or in
combination with different concentrations of growth factors. Twenty- four 3-month-old male
in Calvarial Defects New Zealand white rabbits (weight range, 2.5 to 3.0 kg) that had been bred exclusively for
biomedical research purposes and obtained from a licensed vendor were used. Four calvarial
in a Rabbit Model defects were created in each animal, for a total of 96 defects. Each defect received alloplastic
BCP (Osteon III, Genoss) that was composed of 60% hydroxyapatite and 40% -tricalcium
phosphate) (porosity, ~80%; macropore size, 200 to 400 m; crystallinity, 95%) combined with
different concentrations of recombinant human plateletderived growth factor BB
(rhPDGF-BB), human recombinant basic broblast growth factor-2 (rhFGF-2), or recombinant
human bone morphogenetic protein-2 (rhBMP-2). A custom-made polycarbonate tube was
xed to each defect site by applying slight pressure, and a mixture of bone graft and growth
factor was implanted into the tubes. Data were collected 2, 4, and 8 weeks after creation of the
In Kwon Jung / PhD2
defects to assess early and late healing. Various amounts of newly formed bone and remnant
Byung-Ho Yoon / PhD3 BCP particles formed inside of the tube throughout the study period. The BCP + 0.5 mg/mL
Bok Ryul Choi / PhD4 rhBMP-2 group exhibited the most bone formation. At 8 weeks, more new bone formation was
David M. Kim / DDS, DMSc5 noted in the Osteon III + rhBMP-2 combined group than in other groups. The present study
Jung Sun Jang / MS6 results indicate that BCP can be combined with different concentrations of rhBMP-2, rhFGF-2,
and rhPDGF-BB to produce new bone formation within a polycarbonate tube in calvarial
defects in a rabbit model. Int J Periodontics Restorative Dent 2016;36(suppl):s49s59. doi:
10.11607/prd.2633
1 Assistant Clinical Professor, Department of Restorative Dentistry,
Loma Linda University School of Dentistry, Loma Linda, California, USA.
2 Chief Executive Of cer, Genoss, South Korea. Tooth loss due to periodontal dis- ease, as well as prevalence of peri- implant disease, has
3 Biomaterials Team Manager, Genoss, South Korea. prompted the development of a wide array of bone graft substitutes for use in dentistry.
4 Growth Factor Team Manager, Genoss, South Korea. Clinicians practicing im- plant dentistry need to understand the advantages and disadvantages
5 Assistant Professor, Division of Periodontology, Department of Oral Medicine,
of available bone graft substitutes to achieve a predictable regenera- tive outcome. Alloplastic
Infection andImmunity, Harvard School of Dental Medicine, Boston, Massachusetts, USA.
6 Medical Device Evaluation Team Manager, Genoss, South Korea.
bioma- terials and growth factors offer an alternative to autogenous bone har- vest morbidity
and the unrealized fear of disease transmission with allograft.14 Biphasic calcium phosphate
(BCP), composed of hydroxyapatite (HA) and -tricalcium phosphate (-TCP), is a bone graft
Correspondence to: Dr David M. Kim, Harvard School of Dental Medicine,
substitute that resembles the inorganic phase of human bone tissue.16 The insolu- ble HA re-
188 Longwood Ave, Boston, MA 02115-5819. Fax: 617-432-1872. tains its form and structure to maintain space, while the -TCP stimulates new bone formation
Email: [email protected] by dissolving into calcium and phos- phate ions.56 A number of preclinical and clinical studies
2016 by Quintessence Publishing Co Inc. examining animal and human biopsy specimens of BCP composed of various con- centrations
of HA and -TCP have reported promising results in repairing large alveolar ridge defects.13 In
addition to the os- teoconductive property of BCP, these studies have demonstrated an active
remodeling of the bone with the presence of osteoclast- like multinucleated giant cells lining
70 Research Paper (OSTEON) Research Paper (OSTEON) 71
resorbed graft particles, as well as osteoblasts lining the layers of os- teoid matrix deposited General and local anesthesia
around the graft particles.13 Thus, BCP has been shown to be safe, biocompat- ible, biore- All surgical procedures were per- formed with the rabbits under gen- eral and local
sorbable, and able to ef- fectively serve as a scaffold for new bone formation. anesthesia in sterile conditions. An intramuscular injec- tion of a mixture of Zoletil
Various bone augmentation procedures are required in pa- tients with past dental trauma (0.3 mL/kg; Virbac Laboratories) and xylazine hydrochloride (0.15 mg/kg; Rompun)
or severe periodontal disease. These procedures are a substantial clini- cal challenge because was administered, and the head of the rabbit was shaved and disin- fected with
of their lack of predictability and their surgical demands. One preclinical study observed povidone iodine. Local anesthesia (2% lidocaine hydrochlo- ride [Xylocaine] with
new bone formation in a bone conduction chamber model.7 However, an arti cially created 1:100,000 epi- nephrine) was administered to the surgical site.
crit- ical-size defect model that has been commonly used in other studies may not be able to
guide the bone formation in a designated direction.7 Surgical defect creation and bone augmentation
The present preclinical study was designed to investigate the capability of a new formulation An incision was made along the mid- sagittal plane, and the full-thickness ap was elevated
of BCP (comprising 60% HA and 40% -TCP) in achieving new bone for- mation either by to expose the cal- varia. Four round circular slits (6.9 mm in diameter and 1 mm in depth)
itself or in combina- tion with different concentrations of growth factors. The effect of growth were created using a trephine bur (Dentium). To promote angiogenesis, nine decortications
factors in accelerating the rate of new bone formation was also in- vestigated. The design were made within the circular slit using a round bur 1 mm in diameter. A custom-made
of this study allowed for the comparison of differ- ent concentrations of growth factors that plas- tic tube (height, 5; inner diameter, 6.1 mm; and outer diameter, 7.1 mm)
have been previously investi- gated in guided bone regeneration procedures, as well as in made of polycarbonate (Genoss) was xed to each defect site by apply- ing light pressure,
periodon- tal regeneration procedures. 811 and the mixture of bone graft (0.15 cc) and growth factor (0.15 mg) was implanted into the
tubes. A 15-minute binding time was allowed before insertion. A poly- carbonate cap (Genoss)
Materials and methods
was placed over the tube to prevent soft-tissue ingrowth (Fig 1). The aps were then adapted
for tension-free wound clo- sure with multiple 4-0 resorbable interrupted sutures (Surgicel),
This prospective, randomized con- trolled preclinical trial used male New Zealand white and intramuscular injections of genta- micin (0.15 mL/3 kg) (Kumwha Phar- maceutical)
rabbits to deter- mine the osteogenic impact of BCP in combination with different and diclofenac sodium (0.1 mL/3 kg) (GUJU Pharmaceutical) were administered for 3 days.
con- centrations of growth factors. Study animals and biomaterials Twenty-four
3-month-old male New Zealand white rabbits (weight range, 2.53.0 kg) that had been
Microcomputed tomography (CT), light microscopic,
and histomorphometric analyses
bred ex- clusively for biomedical research purposes were obtained from a licensed vendor.
They were accli- mated for 1 week before research commencement and were fed an Animals were humanely killed at 2, 4, and 8 weeks after the bone aug- mentation procedure.
appropriate diet with ad libitum ac- cess to water. The calvaria were dissected, xed in a 10% formalin solution for 2 weeks, and then evaluated
Four calvarial defects were cre- ated in each animal, for a total of 96 defects. Each defect using CT (SKY- SCAN 1173, Bruker-CT; 130 kV, 60 A, and 12.07 m). Reconstruc- tion of
received an alloplastic BCP (Osteon III, Genoss) that was composed of 60% HA two-dimensional projection images into a three-dimensional (3D) volumetric image stack
and 40% -TCP (porosity, ~80%; macro- pore size, 200400 m; crystallinity, 95%) was performed using NRecon software (version 1.6.9.8; Bruker-CT), and a CT-analyzer soft-
combined with different con- centrations of recombinant human plateletderived ware (version 1.14.4.1; Bruker-CT) was used for morphometric analysis evaluat- ing
growth factor BB (rhPDGF-BB), human recombinant basic broblast growth factor-2 the percentage of mineralized bone and residual graft particles.
(rhFGF-2), or recombinant human bone morphogenetic protein-2 (rh- BMP-2).
After specimens were rinsed, dehydrated in ascending grades of ethanol, and embedded
Data were collected 2, 4, and 8 weeks after creation of the defects to assess early and
in a light- curing one-component composite resin (Technovit 7200 VLC, Heraeus Kulzer),
late heal- ing.12 Each defect site was randomly assigned to one of the following groups,
light microscopic evalua- tion was conducted. Polymerized blocks were ground to bring
with no two adjacent sites receiving the same material:
the tissue components closer to the cutting surface. The nal thickness of 35 m was
achieved by grinding and nal polishing. Sections from each block were used for Goldner
trichrome stain. Light microscopic overview images of the cores were obtained with an
t0TUFPO***POMZ DPOUSPMO
t0TUFPO***NHN- optical micro- scope (BX51, OLYMPUS) equipped with a CCD camera (SPOT Insight 2Mp
t0TUFPO***NHN- SI'(' (FOPTTO
scienti c CCD digital camera system, DIAGNOSTIC Instruments) and analyzed using SPOT
SI1%('## (FOPTTO
t0TUFPO***NHN- (version 4.0, DIAGNOSTIC Instruments) and Image-Pro Plus (Media Cybernet- ics) software.
t0TUFPO***NHN- SI#.1 (FOPTTO
SI1%('## (FOPTTO
t0TUFPO***NHN- Statistical analysis
SI#.1 (FOPTTO
t0TUFPO***NHN- Mean values of newly formed bone and remnant BCP particles at each
SI'(' (FOPTTO
data collection period were com- pared using analysis of variance table of the linear model
t among all the experimental groups. The Tukey test was used for post hoc two-group anal-
yses. Repeated measures for each experimental group at the three data collection periods
were assessed using the analysis of variance model. All sta- tistics were performed using the
R statistical software package. P val- ues less than .05 were considered statistically significant.
72 Research Paper (OSTEON) Research Paper (OSTEON) 73
Fig 2 Representative histologic sections 2 weeks after the creation of calvarial defects in rabbits
(Goldner trichrome stain, magni cation 12.5)
a) Osteon III only (control).
b) Osteon III + 0.15 mg/mL recombinant human plateletderived growth factor BB (rhPDGF-BB).
c) Osteon III + 0.3 mg/mL rhPDGF-BB.
d) Osteon III + 0.5 mg/mL human recombinant basic broblast growth factor-2 (rhFGF-2).
e) Osteon III + 1.0 mg/mL rhFGF-2.
f) Osteon III + 0.5 mg/mL recombinant human bone morphogenetic protein-2 (rhBMP-2).
g) Osteon III + 1.0 mg/mL rhBMP-2.
Fig 1 Polycarbonate caps placed over tubes to prevent soft-tissue ingrowth in calvarial defects in rabbits.
particles formed inside the tube throughout the study period (Figs 2 to 7). Initial bone
Results formation ap- peared to start from the periph- ery of the remaining calvarial bone and
Clinical evaluation move toward the center of the tube and then gradually toward the polycarbonate cap.
No early exposure of the polycar- bonate cap or adverse soft-tissue responses were
observed during the healing period in any groups. CT and histologic evaluations
Various amounts of newly formed bone as well as remnant BCP 2-week specimens
Limited bone formation and slight bony ingrowth originating from the border of the
native bone were ob- served (Fig 2). Remaining BCP par- ticles were easily distinguishable
from the native bone and connec-tive tissue because of differences in staining and
morphologic prop- erties. In some specimens, BCP particles seemed to act as an os-
teoconductive scaffold for bone re- generation, as newly formed bone was observed
around the graft par- ticles. No obvious between-group differences in bone regeneration
were found.
a b 4-week specimens
t week 4, new bone tissue was more de nite in all specimens com- pared with that of week
2 (Figs 3 and 4). Newly formed bone was seen from the external surface of the calvarial
bone to approximately one-third to one-half the height of the tube in the control and both
rh- BMP-2 groups. Formation of bone at the central area of the tube was a common nding
in the control and both rhBMP-2 groups. In the areas with new bone formation, intimate
contact was observed between the graft particles and newly formed bone, and graft
particles were bridged by the newly formed bone. In some specimens, the surface of the
c d
BCP showed signs of resorp- tion. Vascular and bone ingrowth
e f
g
74 Research Paper (OSTEON) Research Paper (OSTEON) 75
into the pores of the biomaterial was also noted in the control and both rhBMP-2 groups, and
the BCP particles were embedded in woven bone and in dense connective tis- sue and mar-
row space. Compared with that of other specimens, robust new bone formation was noted
in both rhBMP-2 groups, with the pat- tern of bone regeneration different from that of other
specimens. rh- BMP-2 appeared to have induced bone more uniformly over the surgi- cal
defects, whereas other growth factors induced bone mainly from the margins of the defects
and pro- ceeding toward the center. Both rh- PDGF-BB groups appeared to have a weaker
a b
bone formation response than the other groups. Bone depo- sition appeared to be delayed
in these two groups, whereas uniform bone formation was observed for the rhBMP-2 groups.
8-week specimens
New bone growth was observed around the graft particles as well as within the structure of
the graft particulate for all groups (Figs 5 and 6). A clear demarcation was not observed be-
tween the grafted area and the native bone in many specimens because uniform and mature
c d bone formation were ob- served at this point. Quality of new bone appeared to be similar to
the surrounding native bone. The rhBMP-2 groups appeared to have generated substantially
more newly formed bone than the other groups, and some specimens had bone formation
extending to the inner aspect of the polycarbonate cap. Histomorphometric analysis
Histomorphometric analysis was performed to compare the amount of newly formed bone
and remain- ing graft materials (Fig 8). The analysis of variance table revealed no differences
in the re- maining bone graft percentages in different experimental groups at 2, 4, or 8 weeks.
No signi cant differ- ence was found in any two-group comparison. Regarding new bone
e f area percentage, signi cant differ- ences were found among different experimental groups
1BUXFFLT1BUXFFLT
*OUIFUXPHSPVQDPNQBSJTPOBOBMZTFTBUXFFLT
the rhBMP-2 groups exhibited statistically signi cantly more new bone formation than the
other experimental groups, ex- cept for the Osteon III + 1.0 mg/mL rhFGF-2 group (P .01).
For each experimental condition at the three data collection periods, a signi - cant increase
JOOFXCPOFBSFBXBTJOEFOUJFEJOUIFDPOUSPM 1
0TUFPO***NHN-SI'(' 1
0TUFPO***NHN-SI'(' 1
BOE0TUFPO***NHN-SI#.1 1
.003) groups. At 2 weeks, the mean standard deviation (SD) percent of new bone was 8.34%
g 5.16% for the control group, 4.37% 2.48% for the Osteon III + 0.15 mg/mL rhPDGF-BB
group, 5.45% 1.90% for the Osteon III + 0.3 mg/mL rhPDGF-BB group, 6.15% 3.43% for the
Fig 3 Representative histologic sections 4 weeks after the creation of calvarial defects in rabbits (Goldner trichrome Osteon III + 0.5 mg/mL rhFGF-2 group, 4.53% 2.06% for the Osteon III + .0 mg/mL rhFGF-2
stain, magni cation 12.5). (a) Osteon III only (control). (b) Osteon III + 0.15 mg/mL recombinant human platelet group, 4.55% 1.68% for the Osteon III + 0.5 mg/mL rhBMP-2 group, and 4.72% 2.83% for
derived growth factor BB (rhPDGF-BB). (c) Osteon III + 0.3 mg/mL rhPDGF-BB. (d) Osteon III + 0.5 mg/mL human
the Osteon III + 1.0 mg/mL rhBMP-2 group. The remaining graft particle percentage ranged
recombinant basic broblast growth factor-2 (rhFGF-2). (e) Osteon III + 1.0 mg/mL rhFGF-2. (f) Osteon III + 0.5 mg/mL
from 17.66% to 27.84% for all groups. No statistically signi cant differences were noted in
recombinant human bone morphogenetic protein-2 (rhBMP-2). (g) Osteon III + 1.0 mg/mL rhBMP-2.
terms of new bone formation at this period. At 4 weeks, the mean SD percent of new bone
was 11.49% 5.70% for the control group, 5.26% 1.24% for the Osteon III + 0.15 mg/mL
OC
NB rhPDGF-BB group, 8.90% 3.41% for the Osteon III + 0.3 mg/mL rhPDGF-BB group, 11.06%
5.77% for the Osteon III + 0.5 mg/mL rhFGF-2 group, 11.25% 2.82% for the Osteon III + 1.0
BG
mg/mL rhFGF-2 group, 17.68% 9.45% for the Osteon III + 0.5 mg/mL rhBMP-2 group, and
OCT
OB
BG
NB 15.10% 4.33% for the Osteon III + 1.0 mg/mL rhBMP-2 group. The remaining graft particle
BG
NB
OCT
percentages ranged from 21.20% to 29.72%. Increased new bone formation was exhibited
OB
OC by the Osteon III + 1.0 mg/mL rhFGF-2 and both rhBMP-2 groups compared with week 2.
OC OB
a c
At 8 weeks, the mean SD percent of new bone was 16.67% 7.60% for the control group,
b OCT
7.28% 2.51% for the Osteon III + 0.15 mg/mL rhPDGF-BB group, 6.09% 1.55% for the Os-
teon III + 0.3 mg/mL rhPDGF-BB group, 8.14% 5.99% for the Osteon III + 0.5 mg/mL rhFGF-2
Fig 4 High-magni cation images of a specimen from (a) the control group depicting the presence of an osteoblast, group, 18.35% 8.50% for the Osteon III + 1.0 mg/mL rhFGF-2 group, 32.75% 6.95% for the
an osteocyte, and new bone; (b) the Osteon III + 0.5 mg/mL rhBMP-2 group demonstrating active bone formation;
and (c) the Osteon III + 1.0 mg/mL rhBMP-2 group depicting bone formation and fragmentation of graft particles
Osteon III + 0.5 mg/mL rhBMP-2 group, and 33.46% 8.67% for the Osteon III + 1.0 mg/mL
(PMEOFSUSJDISPNFTUBJO
0#PTUFPCMBTU0$PTUFPDZUF0$5PTUFPDMBTU/#OFXCPOF#(CPOFHSBGU rhBMP-2 group. The
76 Research Paper (OSTEON) Research Paper (OSTEON) 77
BG
BG
NB OB OB OCT
NB NB
OCT BG
OC
OCT OC
a b a OC b c
Fig 6 High-magni cation images of specimens from (a) the Osteon III + 0.5 mg/mL rhBMP-2 group, (b) the
Osteon III + 0.5 mg/mL rhBMP-2 group, and (c) the Osteon III + 1.0 mg/mL rhBMP-2 group from Fig 5
(PMEOFSUSJDISPNFTUBJO
0#PTUFPCMBTU0$PTUFPDZUF0$5PTUFPDMBTU/#OFXCPOF#(CPOFHSBGU
c d
a b
e f
g
c d
Fig 5 Representative histologic sections 8 weeks after the creation of calvarial defects in rabbits (Goldner trichrome
stain, magni cation 12.5). (a) Osteon III only (control). (b) Osteon III + 0.15 mg/mL recombinant human
plateletderived growth factor BB (rhPDGF-BB). (c) Osteon III + 0.3 mg/mL rhPDGF-BB. (d) Osteon III + 0.5 mg/mL
human recombinant basic broblast growth factor-2 (rhFGF-2). (e) Osteon III + 1.0 mg/mL rhFGF-2. (f) Osteon III + 0. 5
mg/mL recombinant human bone morphogenetic protein-2 (rhBMP-2). (g) Osteon III + 1.0 mg/mL rhBMP-2.
e f
g
78 Research Paper (OSTEON) Research Paper (OSTEON) 79
Fig 7 Representative microcomputed tomography images 8 weeks after the creation of calvarial defects in rabbits. rhPDGF-BB enhanced bone aug- mentation when combined with al- lografts or
(a) Osteon III only (control). (b) Osteon III + 0.15 mg/mL recombinant human plateletderived growth factor BB xenografts.13,14 A minimal amount of the growth factor should be considered because
(rhPDGF-BB). (c) Osteon III + 0.3 mg/mL rhPDGF-BB. (d) Osteon III + 0.5 mg/mL human recombinant basic broblast a high dose does not necessarily generate more bone than a low dose but may in- crease
growth factor-2 (rhFGF-2). (e) Osteon III + 1.0 mg/mL rhFGF-2. (f) Osteon III + 0.5 mg/mL recombinant human bone potential adverse effects and costs.15,16 Thus, the release pro le of the carrier, as well as
morphogenetic protein-2 (rhBMP-2). (g) Osteon III + 1.0 mg/mL rhBMP-2. the size and con guration of the bone defect, may be important considerations for a
growth factorcombined strategy. The present study results in- dicate that BCP can be
percentage of remaining graft particles ranged from 23.56% to 27.92%. Compared with combined with different concentrations of rh- BMP-2, rhFGF-2, and rhPDGF-BB to produce
4-week values, less new bone forma- tion was noted in the Osteon III + 0.3 mg/mL new bone formation within a polycarbonate tube in cal- varial defects in a rabbit model.
rhPDGF-BB and the Osteon III + 0.5 mg/mL rhFGF-2 groups. This preclinical model is commonly used to test the osteogenic potential of b
iomaterials.7,17,18 A 4-week observa- tion period has been determined to be adequate
Discussion for the observation of angiogenesis and bone formation in several animal models when
Advances in recombinant tech- niques have allowed for the com- mercialization of growth bioma- terials have been implemented into the defect areas.7,17,19 A healing peri- od
factors such as rhBMP-2, rhPDGF-BB, and rhF- GF-2, which can be used to enhance patient of 8 weeks has been determined to be adequate for the assessment of late healing,
care. In particular, growth factors provide advantages when treating large defects with such as bone incor- poration, resorption of materials, bone remodeling, or the amount
com- promised remaining alveolar bone. They can also shorten treatment time and of bone regeneration in a rabbit cra- nial model.12 Decortication of the calvaria was
minimize postoperative complications.10 Recent preclinical and clinical studies have performed to allow pro- genitor cell migration from the bone marrow and to facilitate
demon- strated that growth factors such as angiogen- esis. As the study progressed, the percentage of new bone formation increased
in all groups except for the Osteon III + 0.3 mg/mL rhPDGF-BB and Osteon III + 0.5 mg/mL
rhFGF-2 groups. In all specimens, newly gen- erated tissue and mineralized bone were
observed within the con ne- ment of the polycarbonate tube at 4 weeks. Super cial
disintegration or fragmentation of BCP particles into small grains have been previously
re- ported,20 whereas osteoclasts were responsible for material resorption in another
human study.21,22 The high percentage of vital bone in regener- ated sites indicated
that bone cells might still be actively replacing BCP, and additional time may increase
the amount of vital bone formation while reducing the residual graft amount.22
Biomaterial by itself (as in the present control group) has been demonstrated to improve
bone re- generation and similar histologic behavior (as reported in other similar studies).
14 At all data collection pe- riods, the control group (Osteon III only) had more new bone
formation than both Osteon III + rhPDGF-BB groups. Porosity and pore intercon- nectivity
have an effect on the BCPs rate of biodegradation, as well as new bone formation,
vascularization, and graft stability.1 An optimum bal- ance between the stable phase
of HA and the soluble phase of -TCP may have enhanced new bone for- mation.1
The importance of car- rier effect for the growth factor was highlighted by the present
ndings as well as those of Kao et al, who reported a negative effect on bone formation
when rhBMP-2 was added to xenografts.23 In the present study, BCP with a composition
of 60% HA and 40% -TCP may not have been a compatible or effective carrier for rhFGF-2
Fig 8 Bar graph demonstrating mean standard deviation of new bone percentage 2 weeks, 4 weeks, and rhPDGF-BB. In the present study, BCP that was combined with 0.5 mg/mL rh- BMP-2
and 8 weeks after the creation of calvarial defects in rabbits who received biphasic calcium phosphate (Osteon III) resulted in the most new bone formation; at 8 weeks, more new bone formation was noted
BOEEJFSFOUDPODFOUSBUJPOTPGHSPXUIGBDUPSTSI1%('##SFDPNCJOBOUIVNBOQMBUFMFUoEFSJWFEHSPXUI in both rhBMP-2 groups than in other groups. Several preclinical studies have previously
GBDUPS##
SI'('IVNBOSFDPNCJOBOUCBTJDCSPCMBTUHSPXUIGBDUPS
SI#.1SFDPNCJOBOUIVNBO demonstrated ef - cacy of rhBMP-2 and alloplasts such as HA and -TCP in the treatment
bone morphogenetic protein-2.
of critical-sized defects.18,24,25
Conclusions
Results of the present study support the use of BCP graft particulates to stimulate new bone
formation by itself or in mixture with a growth factor, such as rhBMP-2. This com- bination
appeared to be biocom- patible and histologically successful in forming new bone at an
acceler- ated rate. Early and uniform onset of bone formation was noted in both rhBMP-2
groups. Low concentra- tions of rhBMP-2 (0.5 mg/mL) ap- peared to be as effective as high
concentrations (1.0 mg/mL). How- ever, the concentrations of these growth factors for use
with BCP need to be tested in an animal study with a larger sample size.
80 Research Paper (OSTEON) Research Paper (OSTEON) 81
Acknowledgments 16. Ha E, Lemonnier J, Fromigu O, Gunou H, Marie PJ. Bone morphogenetic pro- tein
receptor IB signaling mediates apop- tosis independently of differentiation in
The authors reported no con icts of interest related to this study. This study was spon- osteoblastic cells. J Biol Chem 2004;279: 16501658.
sored by a grant from Genoss. 17. Schmid J, Wallkamm B, Hmmerle CH, Gogolewski S, Lang NP. The signi cance of
angiogenesis in guided bone regen- eration. A case report of a rabbit ex- periment.
References Clin Oral Implants Res 1997;8: 244248.
1. Kim DM, Camelo M, Nevins M, Fateh A, Schupbach P, Nevins M. Alveolar ridge recon 18. Ruh PQ, Kroese-Deutman HC, Wolke JG, Spauwen PH, Jansen JA. Bone in- ductive
struction with a composite allo- plastic biomaterial. Int J Periodontics Restorative properties of rhBMP-2 loaded porous calcium phosphate cement im- plants in cranial
Dent 2012;32:e204e209. defects in rabbits. Bio- materials 2004;25:21232132.
2. Kim DM, Nevins ML, Lin Z,et al. The clin- ical and histologic outcome of dental implant in 19. Boo JS, Yamada Y, Okazaki Y, et al. Tissue-engineered bone using mes- enchymal
large ridge defect regener- ated with alloplast: A randomized con- trolled preclinical trial. stem cells and a biodegrad- able scaffold. J Craniofac Surg 2002;13: 231239.
J Oral Implantol 2013;39:148153. 20. Lindgren C, Hallman M, Sennerby L, Sammons R. Back-scattered electron imaging
3. Nevins M, Nevins ML, Peter S, Kim SW, Lin Z, Kim DM. A prospective, random- ized con and elemental analysis of re- trieved bone tissue following sinus aug- mentation
trolled pre-clinical trial to evalu- ate different formulations of biphasic calcium phosphate with deproteinized bovine bone or biphasic calcium phosphate.
with an hydroxyapa- tite collagen membrane (epub ahead of print 29 Oct 2012]. Clin Oral Implants Res 2010;21:924930.
J Oral Implantol. 21. Tosta M, Cortes AR, Corra L, Pinto DDos S Jr, Tumenas I, Katchburian E. Histologic and
4. Kim DM, De Angelis N, Camelo M, Nev- ins ML, Schupbach P, Nevins M. Ridge histomorphometric eval- uation of a synthetic bone substitute for maxillary sinus
preservation with and without primary wound closure: A case series. grafting in humans. Clin Oral Implants Res 2013;24:866870.
Int J Periodontics Restorative Dent 2013;33: 7178. 22. Frenken JW, Bouwman WF, Bravenboer N, Zijderveld SA, Schulten EA, ten Brug- genkate
5. LeGeros RZ, Lin S, Rohanizadeh R, Mi- jares D, LeGeros JP. Biphasic calcium phosphate CM. The use of Straumann Bone Ceramic in a maxillary sinus oor elevation procedure: A
bioceramics: Preparation, properties and applications. J Mater Sci Mater Med clinical, radio- logical, histological and histomorpho- metric evaluation with a 6-month
2003;14:201209. healing period. Clin Oral Implants Res 2010;21: 201-208.
6. Faria NM, Guzn FM, Pea ML, Can- talapiedra AG. In vivo behaviour of two different 23. Kao DW, Kubota A, Nevins M, Fiorellini JP. The negative effect of combining rh- BMP-2
biphasic ceramic implanted in mandibular bone of dogs. J Mater Sci Mater Med and Bio-Oss on bone formation for maxillary sinus augmentation. Int J Periodontics
2008;19:15651573. Restorative Dent 2012; 32:6167.
7. Tamimi FM, Torres J, Tresguerres I, Cle- mente C, Lpez-Cabarcos E, Blanco LJ. Bone 24. Tazaki J, Murata M, Akazawa T, et al. BMP-2 release and dose-response stud- ies in
augmentation in rabbit calvariae: Comparative study between Bio-Oss and a novel hydroxyapatite and beta-tricalcium phosphate. Biomed Mater Eng 2009;19: 141146.
beta-TCP/DCPD granulate. J Clin Periodontol 2006;33:922928. 25. Lan Levengood SK, Polak SJ, Poellmann MJ, et al. The effect of BMP-2 on micro- and
8. Kaigler D, Avila G, Wisner-Lynch L, et al. Platelet-derived growth factor applica- tions macroscale osteointegration of bi- phasic calcium phosphate scaffolds with multiscale
in periodontal and peri-implant bone regeneration. Expert Opin Biol Ther porosity. Acta Biomater 2010; 6:32833291.
2011;11:375385.
9. Kitamura M, Akamatsu M, Machigashira M, et al. FGF-2 stimulates periodontal
regeneration: Results of a multi-center randomized clinical trial.
J Dent Res 2011; 90:3540.
10. Nevins M, Ho DK, Kwon TW, Al-He- zaimi K, Kim DM. Application of bone morphogenetic
proteins in bone aug- mentation procedure. Journal de Par- odontologie
& dImplantologie Orale 2014;33:159172.
11. Pilipchuk SP, Plonka AB, Monje A, et al. Tissue engineering for bone regen- eration and
osseointegration in the oral cavity. Dent Mater 2015;31:317338.
12. Sohn JY, Park JC, Um YJ, et al. Sponta- neous healing capacity of rabbit cranial defects of
various sizes. J Periodontal Implant Sci 2010;40:180187.
13. Nevins M, Garber D, Hanratty JJ, et al. Human histologic evaluation of anor- ganic bovine
bone mineral combined with recombinant human platelet-de- rived growth factor BB
in maxillary sinus augmentation: Case series study. Int J Periodontics Restorative Dent
2009;29: 583591.
14. Nevins ML, Camelo M, Nevins M, et al. Minimally invasive alveolar ridge aug- mentation
procedure (tunneling tech- nique) using rhPDGF-BB in combination with three
matrices: A case series. Int J Periodontics Restorative Dent 2009;29: 371383.
15. Kenley R, Marden L, Turek T, Jin L, Ron E, Hollinger JO. Osseous regeneration in the rat cal
varium using novel delivery systems for recombinant human bone morphogenetic
protein-2 (rhBMP-2). J Biomed Mater Res 1994;28:11391147.
84 86
OSTEON III Dr. Dong-Wook Chang Dr. Seung-Min Han
Win Dental Clinic Seoul Ichon Dental Clinic
84 OSTEON Clinical Cases OSTEON Clinical Cases 85
C.C.
I have severe pain on the right lower molars.
7/10/2015 Flap reflection 7/10/2015 OSTEON III
Surgery Key Point
When installing implants on lower molar(#46, #47) area,
OSTEON III was applied to treat the bone loss area around the implant
and buccal hard tissue, and the outcome was examined.
Conclusion
When we install implantat the very narrow alveolar ridge, the 3.0mm 7/10/2015 Postoperative 10/20/2015 Second stage Surgery
diameter NR Line implant is the proper selection.
Especially when the orientation of the osteotomy and the restoration
is dierent, a two-piece implant/abutment option is better than the
one-piece SlimLine implant. Moreover, when the space is limited and the
soft tissue level is irregular in shape, it is eective to use a customized
abutment to achieve adequate biologic width around the implant.
C.C.
Bleeding and difficulty in biting on the left side.
Surgery Key Point 6/8/2015 Installation (SuperLine) 6/8/2015 OSTEON lll, OSTEON ll
The regenerative surgery case by SuperLine implant and GENOSS
regenerative material in case where sinus with 1~2 residual alveolar
bone on #26 sites and localized dehiscence defect on #24 site exist.
Specifications are subject to change without notice. Some products listed in this catalog are not available in the market due to pending approval.